$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Packaged pharmaceutical product 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • B65D-065/38
출원번호 US-0559276 (1990-07-27)
발명자 / 주소
  • Carter Douglas V. (Lenoir NC)
출원인 / 주소
  • Entravision, Inc. (Lenoir NC 02)
인용정보 피인용 횟수 : 294  인용 특허 : 0

초록

A method of filling, sealing and sterilizing a pharmaceutical package including a polypropylene bottle containing a balanced salt solution includes the steps of filling each bottle to maximum capacity to exclude residual air, the introduction of a silicone rubber gasket into the bottle cap to absorb

대표청구항

A sterile pharmaceutical package comprising: a) a translucent, resilient polymeric bottle formed of a material capable of withstanding sterilization temperatures without vapor leakage through the walls thereof; b) a cap and means for securing said cap to the open top of said bottle; c) sealing means

이 특허를 인용한 특허 (294)

  1. Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
  2. Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
  3. Raaum, Erik Dean; Potter, Garrett Thomas; Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
  4. Raaum, Erik Dean; Potter, Garrett Thomas; Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
  5. Raaum, Erik Dean; Potter, Garrett Thomas; Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
  6. Raaum, Erik Dean; Potter, Garrett Thomas; Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
  7. Limback, Nancy Gail, A-shaped blister card.
  8. Hostetler, Karl Y.; Beadle, James R.; Valiaeva, Nadejda, Acyclic nucleoside phosphonate diesters.
  9. Hostetler, Karl Y.; Beadle, James R.; Valiaeva, Nadejda, Acyclic nucleoside phosphonate diesters.
  10. Shepard, Harold Michael; Thompson, Curtis; Li, Xiaoming; Frost, Gregory I., Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effects.
  11. Petasis,Nicos A., Amino phosphonate and amino bis-phosphonate derivatives.
  12. Cociorva, Oana; Li, Bei; Szardenings, Anna Katrin; Fukuda, Yasumichi; Nomura, Masahiro; Seto, Shigeki; Yumoto, Kazuhiro; Okada, Kyoko; Nakamura, Ayako, Aminoquinolones as GSK-3 inhibitors.
  13. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment.
  14. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment.
  15. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment.
  16. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment.
  17. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-inflammation methods.
  18. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-inflammation methods.
  19. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-inflammation methods.
  20. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-inflammation methods.
  21. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition.
  22. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition.
  23. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition.
  24. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition.
  25. Chen, Isan; Hager, Jeffrey H; Maneval, Edna Chow; Herbert, Mark R; Smith, Nicholas D, Androgen receptor modulator and uses thereof.
  26. Pedram, Bijan; Van Oeveren, Cornelis Arjan; Zhi, Lin; Zhao, Shuo; Shen, Yixing, Androgen receptor modulator compounds.
  27. Zhi, Lin; Higuchi, Robert I.; Van Oeveren, Cornelis Arjan; Lau, Thomas Lot Stevens, Androgen receptor modulator compounds and methods.
  28. Zhi, Lin; Higuchi, Robert I.; Van Oeveren, Cornelis Arjan; Lau, Thomas Lot Stevens, Androgen receptor modulator compounds and methods.
  29. Zhi, Lin; Higuchi, Robert I.; Van Oeveren, Cornelis Arjan; Lau, Thomas Lot Stevens, Androgen receptor modulator compounds and methods.
  30. Pedram, Bijan; Van Oeveren, Cornelis Arjan; Zhi, Lin; Zhao, Shuo; Shen, Yixing, Androgen receptor modulator methods.
  31. Smith, Nicholas D.; Bonnefous, Celine; Julien, Jackaline D., Androgen receptor modulators and uses thereof.
  32. Smith, Nicholas D.; Bonnefous, Celine; Julien, Jackaline D., Androgen receptor modulators and uses thereof.
  33. Smith, Nicholas D.; Bonnefous, Celine; Julien, Jackaline D., Androgen receptor modulators and uses thereof.
  34. Chen, Isan, Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer.
  35. Chen, Isan, Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer.
  36. Cathers, Brian E.; Correa, Matthew Daniel; Hansen, Joshua; Lopez-Girona, Antonia; Khalil, Ehab M.; MacBeth, Kyle; Man, Hon-Wah; Muller, George W.; Pourdehnad, Michael; Raheja, Raj, Antiproliferative compounds and methods of use thereof.
  37. Cathers, Brian E.; Correa, Matthew Daniel; Hansen, Joshua; Lopez-Girona, Antonia; Khalil, Ehab M.; MacBeth, Kyle; Man, Hon-Wah; Muller, George W.; Pourdehnad, Michael; Raheja, Raj, Antiproliferative compounds and methods of use thereof.
  38. Hansen, Joshua; Correa, Matthew Daniel; Raheja, Raj; Lopez-Girona, Antonia; Man, Hon-Wah; Muller, George W.; Khalil, Ehab M.; MacBeth, Kyle; Cathers, Brian E.; Pourdehnad, Michael, Antiproliferative compounds and methods of use thereof.
  39. Alexander, Matthew D.; Correa, Matthew D.; Hansen, Joshua; Raheja, Raj Kumar; Sapienza, John, Antiproliferative compounds, and their pharmaceutical compositions and uses.
  40. Alexander, Matthew D.; Correa, Matthew D.; Hansen, Joshua; Raheja, Raj Kumar; Sapienza, John, Antiproliferative compounds, and their pharmaceutical compositions and uses.
  41. Spada,Lon T.; Butorac,Paul T.; Gerondale,Scott J., Autoclaveable small-volume dropper bottle.
  42. Zhu, Yong-Liang; Qian, Xiangping, Benzenesulfonamide derivatives of quinoxaline, pharmaceutical compositions thereof, and their use in methods for treating cancer.
  43. Zhu, Yong-Liang; Qian, Xiangping, Benzenesulfonamide derivatives of quinoxaline, pharmaceutical compositions thereof, and their use in methods for treating cancer.
  44. Zhu, Yong-Liang; Qian, Xiangping, Benzenesulfonamide derivatives of quinoxaline, pharmaceutical compositions thereof, and their use in methods for treating cancer.
  45. Petasis, Nicos A., Benzo lipoxin analogues.
  46. Petasis, Nicos A., Benzo lipoxin analogues.
  47. Petasis, Nicos A., Benzo lipoxin analogues.
  48. Petasis, Nicos A., Benzo lipoxin analogues.
  49. Banerjee,Partha S.; Chaudry,Imtiaz A.; Pham,Stephen, Bronchodilating β-agonist compositions and methods.
  50. Banerjee, Partha S.; Chaudry, Imtiaz A.; Pham, Stephen, Bronchodilating Beta-agonist compositions and methods.
  51. Banerjee, Partha S.; Chaudry, Imtiaz A.; Pham, Stephen, Bronchodilating beta-agonist compositions and methods.
  52. Chaudry,Imtiaz A.; Pham,Stephen; Banerjee,Partha S., Bronchodilating beta-agonist compositions and methods.
  53. Chaudry,Imtiaz A.; Pham,Stephen; Banerjee,Partha S., Bronchodilating beta-agonist compositions and methods.
  54. Chaudry,Imtiaz A.; Pham,Stephen; Banerjee,Partha S., Bronchodilating beta-agonist compositions and methods.
  55. Banerjee, Partha S.; Pham, Stephen; Akapo, Samuel O.; Chaudry, Imtiaz A., Bronchodilating compositions and methods.
  56. Banerjee, Partha S.; Pham, Stephen; Akapo, Samuel O.; Chaudry, Imtiaz A., Bronchodilating compositions and methods.
  57. Chaudry, Imtiaz A.; Pham, Stephen; Banerjee, Partha S., Bronchodilating β-agonist compositions and methods.
  58. Chaudry, Imtiaz A.; Pham, Stephen; Banerjee, Partha S., Bronchodilating β-agonist compositions and methods.
  59. Ballatore, Carlo; Castellino, Angelo J; Smith, III, Amos B; Desharnais, Joel; Sun, Chengzao; Aspland, Simon E, C-10 carbamates of taxanes.
  60. Zhang, Jian; Armer, Thomas A., Cabergoline derivatives.
  61. Mecker, Alex; Stanbro, Jason K.; Pieper, Gregory G.; Harrity, Kevin; Gregory, Kara, Cartridge.
  62. Mecker, Alex; Stanbro, Jason K.; Pieper, Gregory G.; Harrity, Kevin; Gregory, Kara, Cartridge.
  63. Qian, Xiangping; Zhu, Yong-Liang, Certain chemical entities, compositions, and methods.
  64. Qian, Xiangping; Zhu, Yong-Liang, Certain chemical entities, compositions, and methods.
  65. Qian, Xiangping; Zhu, Yong-Liang, Certain chemical entities, compositions, and methods.
  66. Qian, Xiangping; Zhu, Yong-liang, Certain chemical entities, compositions, and methods.
  67. Zhu, Yong-Iiang; Qian, Xiangping, Certain chemical entities, compositions, and methods.
  68. Zhu, Yong-liang; Qian, Xiangping, Certain chemical entities, compositions, and methods.
  69. Limback, Nancy Gail, Clamshell having blisters received therein.
  70. Limback, Nancy Gail, Clamshell package having blisters.
  71. Heyman, Peter W., Clear medical packaging.
  72. Janes, Matthew Robert; Patricelli, Matthew Peter; Li, Liansheng; Ren, Pingda; Liu, Yi, Combination therapies for treatment of cancer.
  73. Maneval, Daniel C.; Shepard, H. Michael; Thompson, Curtis B., Combination therapy with an anti-hyaluronan agent and therapeutic agent.
  74. Maneval, Daniel C.; Shepard, H. Michael; Thompson, Curtis B., Combination therapy with an anti-hyaluronan agent and therapeutic agent.
  75. Langecker, Peter; Steiert, Matthias; Hino, Toshiaki; Scicinksi, Jan; Paulvannan, Kumarapandian, Composite nanoparticles and uses thereof.
  76. Li, Xiaoming; Ramprasad, Mysore; Thompson, Curtis; Shepard, Harold Michael; Bookbinder, Louis Howard; Frost, Gregory Ian, Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia.
  77. Gao, Ying-Ying; Tseng, Scheffer, Compositions and methods for treating Demodex infestations.
  78. Wise, David, Compositions and methods for treating pelvic pain and other conditions.
  79. Tseng, Scheffer; He, Hua, Compositions containing HC-HA complex and methods of use thereof.
  80. Tseng, Scheffer; He, Hua; Tighe, Sean; Zhang, Suzhen; Zhu, Ying-Tieng, Compositions containing HC-HA/PTX3 complexes and methods of use thereof.
  81. Tseng, Scheffer; He, Hua; Tighe, Sean; Zhang, Suzhen; Zhu, Ying-Tieng, Compositions containing HC-HA/PTX3 complexes and methods of use thereof.
  82. Bromley, Philip James; Huang, Lee Nickols, Compositions for mucosal delivery of agents.
  83. Bromley, Philip James; Huang, Lee Nickols, Compositions for mucosal delivery of agents.
  84. Bromley, Philip J.; Rahim, Nurruzana; Lam, Koon Zee, Compositions for providing agents that degrade in water.
  85. Thanos, Christopher D.; Wang, Lin; Shepard, H. Michael, Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same.
  86. Tseng, Scheffer; Chua, Lorraine, Compositions of morselized umbilical cord and/or amniotic membrane and methods of use thereof.
  87. Cheng, Soan; Comer, Daniel D.; Mao, Long; Balow, Guity P.; Pleynet, David, Compounds and uses thereof in modulating amyloid beta.
  88. Cheng,Soan; Comer,Daniel D.; Mao,Long; Balow,Guity P.; Pleynet,David, Compounds and uses thereof in modulating amyloid beta.
  89. Cheng, Soan; Comer, Daniel D.; Mao, Long; Balow, Guity P.; Pleynet, David, Compounds and uses thereof in modulating amyloid β.
  90. Wagner, Steven L.; Cheng, Soan; Mobley, William C.; Tanzi, Rudolph E., Compounds and uses thereof in modulating levels of various amyloid beta peptide alloforms.
  91. Cao, Jianguo; Wang, Zhijun; Grey, Jonathan; Rogers, Evan; Whitten, Jeffrey P., Compounds that modulate intracellular calcium.
  92. Rogers, Evan; Cao, Jianguo; Wang, Zhijun; Grey, Jonathan; Whitten, Jeffrey P., Compounds that modulate intracellular calcium.
  93. Lindquist, Susan L.; Outeiro, Tiago; Labaudinière, Richard, Compounds, compositions and methods of inhibiting alpha-synuclein toxicity.
  94. Hoekstra,Todd, Continuous web of breather pouches and automated method of packaging medical devices utilizing such pouches.
  95. Lichter, Jay; Trammel, Andrew M.; Piu, Fabrice; Ye, Qiang; Dellamary, Luis A.; Lebel, Carl; Harris, Jeffrey P., Controlled release antimicrobial compositions and methods for the treatment of OTIC disorders.
  96. Lichter, Jay; Trammel, Andrew M.; Piu, Fabrice; Ye, Qiang; Dellamary, Luis A.; Lebel, Carl; Harris, Jeffrey P., Controlled release antimicrobial compositions and methods for the treatment of otic disorders.
  97. Lichter, Jay; Trammel, Andrew M.; Piu, Fabrice; Ye, Qiang; Dellamary, Luis A.; Lebel, Carl; Harris, Jeffrey P., Controlled release antimicrobial compositions and methods for the treatment of otic disorders.
  98. Lichter, Jay; Trammel, Andrew M.; Piu, Fabrice; Ye, Qiang; Dellamary, Luis A.; Lebel, Carl; Harris, Jeffrey P., Controlled release antimicrobial compositions and methods for the treatment of otic disorders.
  99. Lichter, Jay; Trammel, Andrew M.; Piu, Fabrice; Ye, Qiang; Duron, Sergio G.; Dellamary, Luis A.; Lebel, Carl; Harris, Jeffrey P., Controlled release compositions for modulating free-radical induced damage and methods of use thereof.
  100. Lichter, Jay; Trammel, Andrew M.; Piu, Fabrice; Ye, Qiang; Scaife, Michael Christopher; Vollrath, Benedikt; Duron, Sergio G.; Dellamary, Luis A.; Lebel, Carl; Harris, Jeffrey P., Controlled release compositions for modulating free-radical induced damage and methods of use thereof.
  101. Glidden, Paul F.; Pilgrim, Alison J.; Hanson, Stephen R., Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor.
  102. Glidden, Paul F.; Pilgrim, Alison J.; Hanson, Stephen R., Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor.
  103. Lichter, Jay; Vollrath, Benedikt; Duron, Sergio G.; Lebel, Carl; Piu, Fabrice; Ye, Qiang; Dellamary, Luis A.; Trammel, Andrew M.; Scaife, Michael Christopher; Harris, Jeffrey P., Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders.
  104. Ren, Pingda; Liu, Yi; Li, Liansheng; Feng, Jun; Wu, Tao, Covalent inhibitors of K-Ras G12C.
  105. Ren, Pingda; Liu, Yi; Li, Liansheng; Feng, Jun; Wu, Tao, Covalent inhibitors of Kras G12C.
  106. Purro, Norbert; Smyth, Mark S.; Goldman, Erick; Wirth, David D., Crystalline forms of a Bruton's tyrosine kinase inhibitor.
  107. Purro, Norbert; Smyth, Mark Stephen; Goldman, Erick; Wirth, David D., Crystalline forms of a Bruton's tyrosine kinase inhibitor.
  108. Purro, Norbert; Smyth, Mark; Goldman, Erick; Wirth, David D., Crystalline forms of a Bruton's tyrosine kinase inhibitor.
  109. Purro, Norbert; Smyth, Mark S.; Goldman, Erick; Wirth, David D., Crystalline forms of a bruton's tyrosine kinase inhibitor.
  110. Purro, Norbert; Smyth, Mark S.; Goldman, Erick; Wirth, David D., Crystalline forms of a bruton's tyrosine kinase inhibitor.
  111. Purro, Norbert; Smyth, Mark Stephen; Goldman, Erick; Wirth, David D., Crystalline forms of a bruton's tyrosine kinase inhibitor.
  112. Purro, Norbert; Smyth, Mark Stephen; Goldman, Erick; Wirth, David D., Crystalline forms of a bruton's tyrosine kinase inhibitor.
  113. Girard, Kevin Paul; Jensen, Andrew J.; Jones, Kris Nicole, Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole.
  114. Li, Bei; Szardenings, Anna Katrin, Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors.
  115. Wray, Daniel X.; Halsdorff, Michael B.; De Armond, Robert L., Cyclosiloxane-substituted polysiloxane compounds, compositions containing the compounds and methods of use thereof.
  116. Gordon, Eric M., Deuterated O-sulfated beta lactam hydroxamic acids and deuterated N-sulfated beta lactams.
  117. Gordon, Eric M., Deuterated O-sulfated beta-lactam hydroxamic acids and deuterated N-sulfated beta-lactams.
  118. Lenz, Thomas, Devices, systems and methods for separating magnetic particles.
  119. Palenzuela, Gonzalo, Easy mounting configuration for loudspeaker.
  120. Shin, Hyeon-Cheol; Hwang, Hyejeong; Park, Kwang Yong; Kim, Seong Ho; Lee, Haengwoo, Eckol derivatives, methods of synthesis and uses thereof.
  121. Pandey,Ravindra K.; Dougherty,Thomas J.; Pallenberg,Alexander J., Efficient synthesis of pyropheophorbide a and its derivatives.
  122. Armer, Thomas; McKinley, Geoff; Borland, Scott; Guzman, Miguel; Szabolcs, Ármin; Gerencser, János, Ergoline compounds and uses thereof.
  123. Armer, Thomas; McKinley, Geoff; Borland, Scott; Guzman, Miguel; Szabolcs, Ármin; Gerencser, János, Ergoline compounds and uses thereof.
  124. Armer, Thomas; McKinley, Geoff; Borland, Scott; Guzman, Miguel; Szabolcs, Ármin; Gerencser, János, Ergoline compounds and uses thereof.
  125. Armer, Thomas; McKinley, Geoff; Borland, Scott; Guzman, Miguel; Szabolcs, Ármin; Gerencser, János, Ergoline compounds and uses thereof.
  126. Zhang, Kang; Ding, Sheng, Expandable cell source of neuronal stem cell populations and methods for obtaining and using them.
  127. Wei, Ge; Selvam, Krishnasamy Panneer; Bookbinder, Louis; Frost, Gregory I., Extended soluble PH20 polypeptides and uses thereof.
  128. Madison, Edwin L.; Thanos, Christopher, Factor VII polypeptides that are modified and uses thereof.
  129. Madison, Edwin L.; Thanos, Christopher, Factor VII polypeptides that are modified and uses thereof.
  130. Madison, Edwin L.; Thanos, Christopher, Factor VII polypeptides that are modified and uses thereof.
  131. Pandey, Ravindra K.; Potter, William R.; Dougherty, Thomas J., Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy.
  132. Cook, Robert O.; Zhang, Jian; Armer, Thomas A., Fluoroergoline analogs.
  133. Cook, Robert O.; Zhang, Jian; Armer, Thomas A., Fluoroergoline analogs.
  134. Cook, Robert O.; Zhang, Jian; Armer, Thomas A., Fluoroergoline analogs.
  135. Cook, Robert O.; Zhang, Jian; Armer, Thomas A., Fluoroergoline analogs.
  136. Cook, Robert O.; Zhang, Jian; Armer, Thomas A., Fluoroergoline analogs.
  137. Cook, Robert O.; Zhang, Jian; Armer, Thomas A., Fluoroergoline analogs.
  138. Ruiz, Sr., Rafael; Zhang, Sheng; Krauss, Martin, Foam-tipped elongate blister pack dispensing applicator.
  139. Banerjee, Partha S.; Chaudry, Imtiaz A.; Pham, Stephen, Formoterol/steroid bronchodilating compositions and methods of use thereof.
  140. Banerjee, Partha S.; Chaudry, Imtiaz A.; Pham, Stephen, Formoterol/steroid bronchodilating compositions and methods of use thereof.
  141. Banerjee, Partha S.; Chaudry, Imtiaz; Pham, Stephen, Formoterol/steroid bronchodilating compositions and methods of use thereof.
  142. Atluri, Harisha; Chong, Ching Wah; Kuehl, Robert; Shu, Cassandra; Tay, Pearl Shwe-Cho; Hulvat, James Francis; McVey, Alexander Jacob; Minikis, Ryan Mitchell, Formulations of a Bruton's tyrosine kinase inhibitor.
  143. Tanzi, Rudolph E.; Wagner, Steven L.; Cheng, Soan; Mobley, William C., Gamma-secretase modulators.
  144. Messmer, Davorka; Saenz, Rebecca, HMGB1-derived peptides enhance immune response to antigens.
  145. Messmer, Davorka; Saenz, Rebecca, HMGB1-derived peptides enhance immune response to antigens.
  146. Martin,Richard; Flatt,Brenton T; Kahl,Jeffrey D; Wang,Tie Lin, Heterocyclic modulators of nuclear receptors.
  147. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Hyaluronidase and factor VIII compositions.
  148. Shepard, H. Michael; Li, Xiaoming; Thompson, Curtis, Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods.
  149. Beaton, Graham; Tucci, Fabio; Ravula, Satheesh B.; Wang, Hua-Yu, Inhibition of OLIG2 activity.
  150. Chen, Wei; Wang, Longcheng; Jia, Zhaozhong J., Inhibitors of Bruton's tyrosine kinase.
  151. Honigberg, Lee; Verner, Erik; Buggy, Joseph J.; Loury, David; Chen, Wei, Inhibitors of Bruton's tyrosine kinase.
  152. Li, Liansheng; Feng, Jun; Ren, Pingda; Liu, Yi, Inhibitors of KRAS G12C mutant proteins.
  153. Ren, Pingda; Liu, Yi; Li, Liansheng; Feng, Jun, Irreversible covalent inhibitors of the GTPase K-Ras G12C.
  154. Zhang, Jian; Cook, Robert O., Iso-ergoline derivatives.
  155. Zhang, Jian; Cook, Robert O., Iso-ergoline derivatives.
  156. Zhang, Jian; Cook, Robert O., Iso-ergoline derivatives.
  157. Armer, Thomas; McKinley, Geoff; Borland, Scott; Guzman, Miguel, Isoergoline compounds and uses thereof.
  158. Armer, Thomas; McKinley, Geoff; Borland, Scott; Guzman, Miguel, Isoergoline compounds and uses thereof.
  159. Armer, Thomas; McKinley, Geoff; Borland, Scott; Guzman, Miguel, Isoergoline compounds and uses thereof.
  160. Ly, Tai Wei; Potter, Garrett Thomas, Isotopically enriched arylsulfonamide CCR3 antagonists.
  161. Ly, Tai Wei; Potter, Garrett Thomas, Isotopically enriched arylsulfonamide CCR3 antagonists.
  162. Hostetler, Karl Y.; Beadle, James R., Lung-targeted drugs.
  163. Hostetler, Karl Y.; Beadle, James R., Lung-targeted drugs.
  164. Patricelli, Matthew P.; Peters, Ulf; Li, Liansheng; Ren, Pingda; Liu, Yi, Method for screening inhibitors of Ras.
  165. Gao, Ying-Ying; Tseng, Scheffer, Method for treating ocular Demodex .
  166. Li, Liansheng; Feng, Jun; Long, Yun Oliver; Ren, Pingda; Liu, Yi, Methods and compositions for inhibition of Ras.
  167. Bulla, Jr., Lee A.; Clark, Jeffrey Marcus; Clark, legal representative, Ralph; Griko, Natalya; Sun, Jian, Methods and compositions for modulating an immune response with immunogenic oligonucleotides.
  168. Mani, Neelakandha S.; Allison, Brett D.; Sales, Zachary S.; Liang, Jimmy T.; Deng, Xiaohu; Li, Liansheng; Long, Yun Oliver; Liu, Yuan; Ren, Pingda, Methods for preparation of quinazoline derivatives.
  169. Bookbinder, Louis; Kundu, Anirban; Frost, Gregory I., Methods for reducing intraocular pressure by administering a soluble hyaluronidase glycoprotein (sHASEGP).
  170. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Methods for treating a disease characterized by an excess of hyaluronan by administering a soluble hyaluronidase glycoprotein (sHASEGP).
  171. Bookbinder, Louis; Kundu, Anirban; Frost, Gregory I., Methods for treating edema by administering a Soluble Hyaluronidase Glycoprotein (sHASEGP).
  172. Tseng, Scheffer; Tan, Ek Kia; He, Hua, Methods of modulating bone remodeling.
  173. Tseng, Scheffer; Tan, Ek Kia; He, Hua, Methods of modulating bone remodeling.
  174. Tseng, Scheffer; Tan, Ek Kia; Chua, Lorraine, Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof.
  175. Tseng, Scheffer; Tan, Ek Kia, Methods of sterilizing fetal support tissues.
  176. Tseng, Scheffer; Tan, Ek Kia, Methods of sterilizing fetal support tissues.
  177. Gualberto, Antonio; Scholz, Catherine Rose, Methods of treating cancer with farnesyltransferase inhibitors.
  178. Gualberto, Antonio; Scholz, Catherine Rose, Methods of treating cancer with farnesyltransferase inhibitors.
  179. Keller, Gilbert; Frost, Gregory I., Methods of treatment of cellulite.
  180. Keller, Gilbert; Frost, Gregory I., Methods of treatment of collagen-mediated diseases and conditions.
  181. Armstrong, Robert C.; Belli, Barbara A., Methods of treatment using combination therapy.
  182. Armstrong, Robert C.; Belli, Barbara A., Methods of treatment using combination therapy.
  183. Wu, Libo; Zhang, Jian, Methysergide derivatives.
  184. Malakhov, Michael P.; Li, Tiejun, Microparticle formulations for delivery to the lower and central respiratory tract and methods of manufacture.
  185. Oyhenart, Jorge; Gallet, Xavier; Borrelly, Gilles; Guyon, Thierry; Vega, Manuel; Drittanti, Lila, Modified coagulation factor IX polypeptides and use thereof for treatment.
  186. Guyon, Thierry; Borrelly, Gilles; Gallet, Xavier; Drittanti, Lila; Vega, Manuel, Modified erythropoietin polypeptides and uses thereof for treatment.
  187. Madison, Edwin L.; Thanos, Christopher; Blouse, Grant Ellsworth, Modified factor IX polypeptides and uses thereof.
  188. Madison, Edwin L.; Thanos, Christopher; Blouse, Grant Ellsworth, Modified factor IX polypeptides and uses thereof.
  189. Guyon, Thierry; Borrelly, Gilles; Drittanti, Lila; Vega, Manuel, Modified growth hormone.
  190. Guyon, Thierry; Borrelly, Gilles; Drittanti, Lila; Vega, Manuel, Modified growth hormones.
  191. Guyon, Thierry; Borrelly, Gilles; Drittanti, Lila; Vega, Manuel, Modified growth hormones that exhibit increased protease resistance and pharmaceutical compositions thereof.
  192. Bayne, Christopher D.; Johnson, Alan T.; Lu, Shao Po; Mohan, Raju; Nyman, Michael C.; Schweiger, Edwin J.; Stevens, Jr., William C.; Wang, Haixia; Xie, Yinong, Modulators of LXR.
  193. Bayne, Christopher D.; Johnson, Alan T.; Lu, Shao-Po; Mohan, Raju; Griffith, Ronald C., Modulators of LXR.
  194. Pandey, Ravindra K.; Goswami, Lalit; Spernyak, Joseph; Kanter, Peter; Mazurchuk, Richard, Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents.
  195. Chan Ming Fai ; Wu Chengde ; Raju Bore Gowda ; Kogan Timothy ; Kois Adam ; Verner Erik Joel ; Castillo Rosario Silvestre ; Yalamoori Venkatachalapathi ; Balaji Vitukudi Narayanaiyengar, N-Alkyl, N-Alkenyl, N-Alkynyl, N-Aryl and N-fused bicyclo or tricyclo thienyl-, furyl-,and Pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin.
  196. Cook, Robert O.; Zhang, Jian; Armer, Thomas A., Neuromodulatory compounds.
  197. Head, Brian P.; Patel, Piyush M.; Patel, Hemal; Roth, David M., Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord.
  198. Head, Brian P.; Patel, Piyush M.; Patel, Hemal; Roth, David M., Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord.
  199. Wei, Ge; Selvam, Krishnasamy Panneer; Bookbinder, Louis; Frost, Gregory I., Neutral active soluble truncated PH20 polypeptides and uses thereof.
  200. Hostetler, Karl Y.; Beadle, James R.; Valiaeva, Nadejda, Nucleotide analogs.
  201. Szalay, Aladar A.; Cappello, Joseph; Chen, Nanhai G.; Minev, Boris, Oncolytic virus adjunct therapy with agents that increase virus infectivity.
  202. Ostrow, Gregory I.; Widder, Kenneth J.; Baker, David S., Ophthalmic Composition.
  203. Ostrow, Gregory I.; Widder, Kenneth J.; Baker, David S., Ophthalmic composition.
  204. Dong, Qing; Pierre, Fabrice; Wang, Jianqiang, P-38 inhibitors.
  205. Wei, Ge; Shepard, H. Michael; Zhao, Qiping; Connor, Robert James, PH20 polypeptide variants, formulations and uses thereof.
  206. Taskis Charles Bernard,GBX ; Whatmore Paul John,GBX, Package.
  207. Kis,Gyorgy Lajos; Krautler,Eckhard, Package for a pharmaceutical product and method of sterilizing the package.
  208. Limback, Nancy Gail, Package for product.
  209. Limback, Nancy Gail, Package for product.
  210. Limback, Nancy Gail, Package with break-away clamshell.
  211. Limback, Nancy Gail, Package with break-away clamshell.
  212. Godfrey Thomas E. ; Usher Christopher T. ; Knauss Eric ; Mason ; Sr. Wayne G., Pharmaceutical containment package.
  213. Chong, Ching W.; Kuehl, Robert; Tan, Heow; Atluri, Harisha, Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitor.
  214. Chong, Ching W.; Kuehl, Robert; Tan, Heow; Atluri, Harisha, Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitor.
  215. Chong, Ching W.; Kuehl, Robert; Tan, Heow; Atluri, Harisha, Pharmaceutical formulations of a bruton's tyrosine kinase inhibitor.
  216. Ly, Tai Wei; Raaum, Erik Dean, Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors.
  217. Hostetler, Karl Y.; Wan, W. Brad, Pharmacologically active agents containing esterified phosphonates and methods for use thereof.
  218. Hostetler, Karl Y.; Wan, W. Brad, Pharmacologically active agents containing esterified phosphonates and methods for use thereof.
  219. Byrd, John C.; Woyach, Jennifer A., Phospholipase C gamma 2 and resistance associated mutations.
  220. Hostetler, Karl Y.; Beadle, James R.; Choo, Hyunah, Phosphono-pent-2-en-1-yl nucleosides and analogs.
  221. Zaveri, Nurulain; Meyer, Michael, Piperdinyl nociceptin receptor compounds.
  222. Madison, Edwin L.; Brunck, Terence K.; Semple, Joseph Edward; Lim-Wilby, Marguerita; Pryor, Kent E., Plasminogen activator inhibitor antagonists.
  223. Madison, Edwin L.; Brunck, Terence K.; Semple, Joseph Edward; Lim-Wilby, Marguerita; Pryor, Kent E.; Lewis, II, Ronald D.; Duncan, David F.; Lawrence, C. Maxwell, Plasminogen activator inhibitor antagonists.
  224. Kellermann, Gottfried H.; Huisman, Han J. G., Preparing hapten-specific antibodies and their application for immunodiagnostics and research.
  225. Shing,Yuen Kim, Product packaging.
  226. Madison, Edwin L., Protease screening methods and proteases identified thereby.
  227. Madison, Edwin L., Protease screening methods and proteases identified thereby.
  228. Madison, Edwin L., Protease screening methods and proteases identified thereby.
  229. Tseng, Scheffer; He, Hua; Li, Wei, Purified amniotic membrane compositions and methods of use.
  230. Tseng, Scheffer; He, Hua; Li, Wei, Purified amniotic membrane compositions and methods of use.
  231. Tseng, Scheffer; He, Hua; Li, Wei, Purified amniotic membrane compositions and methods of use.
  232. Tseng, Scheffer; He, Hua; Li, Wei, Purified amniotic membrane compositions and methods of use.
  233. Daniels, David J.; Parney, Ian F.; Peterson, Timothy E., Pyrazole derivatives as inhibitors of STAT3.
  234. Daniels, David J.; Parney, Ian F.; Peterson, Timothy E., Pyrazole derivatives as inhibitors of STAT3.
  235. Chen, Wei; Loury, David J., Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors.
  236. Chen, Wei; Loury, David J.; Wang, Longcheng, Pyrrolopyrimidine compounds as kinase inhibitors.
  237. Tuttle, Susan Bane; Dilek, Ozlem; Mukherjee, Kamalika, Rapid and efficient bioorthogonal ligation reaction and boron-containing heterocycles useful in conjunction therewith.
  238. Zhi, Lin, Selective androgen receptor modulators (SARMS) and uses thereof.
  239. Zhi, Lin, Selective androgen receptor modulators (SARMs) and uses thereof.
  240. Zhi, Lin, Selective androgen receptor modulators (SARMs) and uses thereof.
  241. Zhi, Lin, Selective androgen receptor modulators (SARMs) and uses thereof.
  242. Zhi, Lin, Selective androgen receptor modulators (SARMs) and uses thereof.
  243. Shreder, Kevin; Hu, Yi; Fraser, Allister; Kohno, Yasushi; Kojima, Akihiko; Ishiyama, Junichi, Serine hydrolase inhibitors.
  244. Pang, Yuan-Ping; Park, Jewn Giew; Tang, Jing; Millard, Charles B.; Schmidt, James J., Small-molecule botulinum toxin inhibitors.
  245. Pang, Yuan-Ping; Park, Jewn Giew; Wang, Shaohua; Vummenthala, Anuradha; Mishra, Rajesh K; Davis, Jon; Millard, Charles B.; Schmidt, James J., Small-molecule botulinum toxin inhibitors.
  246. Fernandez, Paul F.; Ferretti, Antonio C.; Kothare, Mohit A.; Li, Ying; Man, Hon-Wah; Zhang, Weihong, Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses.
  247. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  248. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  249. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  250. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  251. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  252. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  253. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  254. Bookbinder, Louis; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  255. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof.
  256. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof.
  257. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof.
  258. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof.
  259. Bookbinder, Louis H.; Kundu, Anirbau; Frost, Gregory I., Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof.
  260. Bookbinder, Louis; Kundu, Anirban; Frost, Gregory I., Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof.
  261. Cociorva, Oana; Fukuda, Yasumichi; Kohno, Yasushi; Li, Bei; Okada, Kyoko; Nakamura, Ayako; Nomura, Masahiro; Seto, Shigeki; Szardenings, Anna Katrin; Yumoto, Kazuhiro, Spirocyclic aminoquinolones as GSK-3 inhibitors.
  262. Cociorva, Oana; Fukuda, Yasumichi; Kohno, Yasushi; Li, Bei; Okada, Kyoko; Nakamura, Ayako; Nomura, Masahiro; Seto, Shigeki; Szardenings, Anna Katrin; Yumoto, Kazuhiro, Spirocyclic aminoquinolones as GSK-3 inhibitors.
  263. Teschner, Wolfgang; Svatos, Sonja; Bruckschwaiger, Leopold; Weber, Alfred; Schwarz, Hans-Peter; Lei, Laura, Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof.
  264. Yang, Tzung-Horng; Vaughn, Daniel Edward; Labarre, Michael James; Caster, Christopher L.; Nicol, Francois; Kim, Donghyun, Stable formulations of a hyaluronan-degrading enzyme.
  265. Conner, Nora M.; Schumacher, Megan T., Sterile medication identification delivery and application system.
  266. Coleman, Scott H.; Liaw, Wei-Cheng; Wroblewski, Jerry; Savel, Robert, Sterilization of ciprofloxacin composition.
  267. Coleman, Scott H.; Liaw, Wei-Cheng; Wroblewski, Jerry; Savel, Robert, Sterilization of ciprofloxacin composition.
  268. Zhang, Jian; Cook, Robert O.; Armer, Thomas A.; Kosarev, Sergey Alexandrovich; Xie, Dejian, Substituted indolo 4,3 FG quinolines useful for treating migraine.
  269. Chan Ming Fai ; Balaji Vitukudi Narayanaiyengar ; Castillo Rosario Silvestre ; Kois Adam ; Raju Bore Gowda ; Wu Chengde, Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin.
  270. Chan Ming Fai ; Balaji Vitukudi Narayanaiyengar ; Castillo Rosario Silvestre ; Kois Adam ; Raju Bore Gowda ; Wu Chengde, Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin.
  271. Li, Liansheng; Feng, Jun; Long, Yun Oliver; Liu, Yuan; Wu, Tao; Ren, Pingda; Liu, Yi, Substituted quinazoline compounds and methods of use thereof.
  272. Li, Liansheng; Feng, Jun; Long, Yun Oliver; Liu, Yuan; Wu, Tao; Ren, Pingda; Liu, Yi, Substituted quinazoline compounds and methods of use thereof.
  273. Li, Liansheng; Feng, Jun; Wu, Tao; Ren, Pingda; Liu, Yi; Liu, Yuan; Long, Yun Oliver, Substituted quinazolines as inhibitors of KRAS G12C.
  274. Qian, Xiangping; Zhu, Yong-Liang, Substituted quinazolines for inhibiting kinase activity.
  275. Qian, Xiangping; Zhu, Yong-Liang, Substituted quinazolines for inhibiting kinase activity.
  276. Qian, Xiangping; Zhu, Yong-Liang, Substituted quinazolines for inhibiting kinase activity.
  277. Qian, Xiangping; Zhu, Yong-Liang, Substituted quinoxalines as B-RAF kinase inhibitors.
  278. Qian, Xiangping; Zhu, Yong-Liang, Substituted quinoxalines as B-raf kinase inhibitors.
  279. Qian, Xiangping; Zhu, Yong-liang, Substituted quinoxalines as B-raf kinase inhibitors.
  280. Qian, Xiangping; Zhu, Yong-liang, Substituted quinoxalines for inhibiting kinase activity.
  281. Wu, Chengde; Blok, Natalie; Holland, George W., Sulfonamides and derivatives thereof that modulate the activity of endothelin.
  282. Frost, Gregory I.; Bilinsky, Igor; Vaughn, Daniel; Sugarman, Barry, Super fast-acting insulin compositions.
  283. Malakhov, Michael P.; Fang, Fang, Technology for preparation of macromolecular microspheres.
  284. Cheruvallath,Zacharia S.; Loweth,Colin J.; Nutt,Ruth F.; Rideout,Darryl; Semple,Joseph E.; Wang,Jing; Wu,Feiyue; Mylvaganam,Shankari; Zhu,Hengyi; Sun,Jianzhong, Thiazole and thiadiazole inhibitors of tyrosine phosphatases.
  285. Buggy, Joseph J.; Elias, Laurence; Fyfe, Gwen; Hedrick, Eric; Loury, David J.; Mody, Tarak D., Use of inhibitors of Bruton'S tyrosine kinase (Btk).
  286. Buggy, Joseph J.; Elias, Laurence; Fyfe, Gwen; Hedrick, Eric; Loury, David J.; Mody, Tarak D., Use of inhibitors of Bruton's tyrosine kinase (Btk).
  287. Buggy, Joseph J.; Elias, Laurence; Fyfe, Gwen; Hedrick, Eric; Loury, David J.; Mody, Tarak D., Use of inhibitors of Bruton's tyrosine kinase (Btk).
  288. Buggy, Joseph J.; Elias, Laurence; Fyfe, Gwen; Hedrick, Eric; Loury, David J.; Mody, Tarak D., Use of inhibitors of bruton'S tyrosine kinase (BTK).
  289. Buggy, Joseph J.; Elias, Laurence; Fyfe, Gwen; Hedrick, Eric; Loury, David J.; Mody, Tarak D., Use of inhibitors of bruton's tyrosine kinase (BTK).
  290. Buggy, Joseph J.; Elias, Laurence; Fyfe, Gwen; Hedrick, Eric; Loury, David J.; Mody, Tarak D., Use of inhibitors of bruton's tyrosine kinase (Btk).
  291. Pandey, Ravindra K.; Gryshuk, Amy; Goswami, Lalit; Potter, William; Oseroff, Allan, Water soluble tetrapyrollic photosensitizers for photodynamic therapy.
  292. Pandey,Ravindra K.; Gryshuk,Amy; Goswami,Lalit; Potter,William; Oseroff,Allan, Water soluble tetrapyrollic photosensitizers for photodynamic therapy.
  293. Cheng, Soan; Comer, Daniel D.; Mao, Long; Balow, Guity P.; Pleynet, David, α-Haloketone derivatives of imidazolyl-substituted aromatic compounds and compounds prepared therefrom.
  294. Cheng, Soan; Comer, Daniel D; Mao, Long; Balow, Guity P; Pleynet, David, α-Haloketone derivatives of imidazolyl-substituted aromatic compounds and compounds prepared therefrom.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로